Regional Virology Laboratory, All India Institute of Medical Sciences Bhopal, Saket Nagar, Bhopal 464020, India.
Regional Virology Laboratory, All India Institute of Medical Sciences Bhopal, Saket Nagar, Bhopal 464020, India.
Infect Genet Evol. 2019 Jun;70:72-79. doi: 10.1016/j.meegid.2019.02.024. Epub 2019 Feb 22.
In view of paucity of information on serotype distribution of Dengue virus (DENV) in Central India, we undertook a cross-sectional study to identify clinical and virological characteristics of DENV serotypes that circulated in this region during the 2016 outbreak. Suspected cases were screened by ELISA for NS1 antigen and anti-DENV IgM antibodies. Serologically confirmed cases were subjected to RT-PCR based detection and serotyping. The RT-PCR results were confirmed by nucleotide sequencing. Genome-wide association was undertaken with DENV sequences from ViPR database and the immune evasion potential of infecting serotypes was ascertained by computing antigenic variability in B cell and Cytotoxic T cell (CTL) epitopes of all DENV proteins. The immunological basis of more prolonged viremia in DENV2-infected patients was also addressed through sequencing of NS2a gene and comparing the CTL activity in NS2a sequences identified among patients with ≤5 days and >5 days of illness. Among 166 serologically confirmed Dengue patients, 75 were positive for DENV RNA. Serotyping revealed predominance of DENV-1 and DENV-2, followed by DENV-3. Co-infection with multiple serotypes was observed in 15.5% of cases. In ~40% cases, DENV RNA was detectable beyond 5 days, among whom majority were DENV-2 infected (p = .044). Highest prevalence of antigenic variability was observed in B cell and CTL epitopes of DENV-2. The potential association between prolonged viremia and higher ability for immune evasion in DENV-2 patients was further corroborated with the observation of poorer HLA-I binding affinity in CTL epitopes observed in NS2a sequences retrieved from patients with >5 days of illness, compared to those with ≤5 days. This is the first report from central India revealing circulation of all DENV serotypes and high prevalence of co-infection with multiple serotypes. We also observed prolonged viremia upon DENV-2 infection, which could be potentially associated with its superior immune evasion potential.
鉴于印度中部地区登革热病毒 (DENV) 血清型分布信息匮乏,我们进行了一项横断面研究,以确定该地区 2016 年疫情期间循环的 DENV 血清型的临床和病毒学特征。通过 ELISA 检测 NS1 抗原和抗 DENV IgM 抗体对疑似病例进行筛查。对血清学确诊病例进行基于 RT-PCR 的检测和血清分型。通过核苷酸测序对 RT-PCR 结果进行确认。与 ViPR 数据库中的 DENV 序列进行全基因组关联,并通过计算所有 DENV 蛋白的 B 细胞和细胞毒性 T 细胞 (CTL) 表位的抗原变异性来确定感染血清型的免疫逃逸潜力。还通过 NS2a 基因测序并比较在疾病持续时间≤5 天和>5 天的患者中鉴定的 NS2a 序列中的 CTL 活性,来解决 DENV2 感染患者中病毒血症持续时间更长的免疫学基础问题。在 166 例血清学确诊的登革热患者中,有 75 例 DENV RNA 阳性。血清分型显示 DENV-1 和 DENV-2 为主,其次是 DENV-3。15.5%的病例存在多种血清型混合感染。在~40%的病例中,DENV RNA 可检测到超过 5 天,其中大多数为 DENV-2 感染(p=0.044)。在 DENV-2 中观察到 B 细胞和 CTL 表位的抗原变异性最高。在 NS2a 序列中观察到更长的病毒血症与 DENV-2 患者更高的免疫逃逸能力之间的潜在关联,这进一步得到了证实,与疾病持续时间≤5 天的患者相比,从疾病持续时间>5 天的患者中检索到的 NS2a 序列中的 CTL 表位 HLA-I 结合亲和力较差。这是印度中部地区首例报告显示所有 DENV 血清型循环和多种血清型混合感染高发的报告。我们还观察到 DENV-2 感染后的病毒血症持续时间延长,这可能与其较强的免疫逃逸潜力有关。